Siemens Healthineers AG
XETRA:SHL

Watchlist Manager
Siemens Healthineers AG Logo
Siemens Healthineers AG
XETRA:SHL
Watchlist
Price: 50.66 EUR -0.16% Market Closed
Market Cap: 57.1B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one SHL stock under the Base Case scenario is 74.3 EUR. Compared to the current market price of 50.66 EUR, Siemens Healthineers AG is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SHL Relative Value
Base Case
74.3 EUR
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
79
vs Industry
41
Median 3Y
2.7
Median 5Y
2.7
Industry
2.3
Forward
2.4
More Details
28.6
P/E
P/E
Price to Earnings
28.6
vs History
66
vs Industry
20
Median 3Y
31.7
Median 5Y
31.2
Industry
22.7
Forward
20
More Details
16.5
P/OCF
P/OCF
Price to OCF
16.5
vs History
98
vs Industry
23
Median 3Y
24.8
Median 5Y
22.3
Industry
13.8
More Details
26.9
P/FCFE
P/FCFE
Price to FCFE
26.9
vs History
93
vs Industry
17
Median 3Y
44.5
Median 5Y
35.9
Industry
19.6
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
92
vs Industry
29
Median 3Y
3.2
Median 5Y
3.4
Industry
2.2
More Details
3
EV/S
EV/S
Enterprise Value to Sales
3
vs History
68
vs Industry
35
Median 3Y
3.1
Median 5Y
3.1
Industry
2.4
Forward
2.8
More Details
7.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.8
vs History
71
vs Industry
27
Median 3Y
8.5
Median 5Y
8.3
Industry
5
More Details
16.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.3
vs History
60
vs Industry
21
Median 3Y
17.4
Median 5Y
17.2
Industry
12
Forward
13.5
More Details
23.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.3
vs History
68
vs Industry
18
Median 3Y
26
Median 5Y
24.9
Industry
16.5
Forward
17.6
More Details
19.7
EV/OCF
EV/OCF
Enterprise Value to OCF
19.7
vs History
90
vs Industry
19
Median 3Y
29.2
Median 5Y
25.5
Industry
13.5
More Details
25.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.1
vs History
96
vs Industry
18
Median 3Y
44.3
Median 5Y
36
Industry
17
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
79
vs Industry
44
Median 3Y
1.7
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

SHL Competitors Multiples
Siemens Healthineers AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Siemens Healthineers AG
XETRA:SHL
56.7B EUR 2.5 28.6 16.3 23.3
US
Abbott Laboratories
NYSE:ABT
227.5B USD 5.4 17 22.7 33.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.9B USD 21.7 77.9 60.4 73.3
US
Boston Scientific Corp
NYSE:BSX
148.5B USD 8.9 80.2 36.6 51.7
US
Stryker Corp
NYSE:SYK
140.2B USD 6.2 46.8 24.3 29.3
IE
Medtronic PLC
NYSE:MDT
114.2B USD 3.4 26.8 14.3 20.1
US
Becton Dickinson and Co
NYSE:BDX
66.3B USD 3.2 37.9 15.8 28.4
US
Edwards Lifesciences Corp
NYSE:EW
41.9B USD 7.7 10 23.6 26
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
291.8B CNY 7.9 23.6 20.6 20.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.3B USD 1.9 18.7 13.1 16
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.5B USD 8.8 38.8 27.6 30.8

See Also

Summary
SHL intrinsic value, competitors valuation, and company profile.
DCF Valuation
SHL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SHL stock valuation using valuation multiples.
Wall Street Estimates
SHL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SHL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.